CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, is pleased to announce its participation at the upcoming H.C. Wainwright 28th Annual Global Investment Conference, taking place September 14–16, 2026, in New York City. Dr. Phillip Chan, Chief Executive Officer and Peter Mariani, Chief Financial Officer of CytoSorbents will be attending the conference, joining Sean Lee, Vice Pr